FDA Investigator: Kejun Cheng
- Kejun Cheng first started conducting FDA inspections in 2017, with the last inspection in 2024. Over that time, Kejun Cheng has conducted 9 inspections at 9 companies across 9 sites.
Get Kejun Cheng's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Zhaoke Pharmaceutical (Hefei) Company Limited, Hefei | 2024
Out-of-stock
Kejun Cheng
Human Drugs Form 483
FDA 483 Berlimed, S.A., Alcala de Henares | 2024
Out-of-stock
Kejun Cheng
Human Drugs Form 483
FDA 483 Centaur Pharmaceuticals Private Ltd., Hinjevadi | 2020
Out-of-stock
Kejun Cheng
Human Drug Form 483
FDA 483 Intas Pharmaceuticals Limited, Ahmedabad | 2019
Out-of-stock
Kejun Cheng
Human Drug Form 483
FDA 483 Norgine Limited, Hengoed | 2017
Out-of-stock
Kejun Cheng
Human Drug Form 483
Co-Investigators (12)
- Marcellinus D. Dordunoo, FDA Investigator
- Taichun Qin, FDA Investigator
- Jazmine N. Brown, FDA Investigator
- Yvins Dezan, FDA Investigator
- Monica C. Burgos Garcia, FDA Investigator
- Farhana Khan, FDA Investigator
- Rebecca E. Dombrowski, FDA Investigator
- Burgos Garcia, Monica C, FDA Investigator
- Patric C. Klotzbuecher, FDA Investigator
- Steven P. Donald, FDA Investigator
- Kham Phommachanh, FDA Investigator
- Nicole E. Knowlton, FDA Investigator